Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTAMISE: Teriparatide Effectiveness After Prior Alendronate or Risedronate
NCT00130403Phase 4Completed
- Sponsor
- Sanofi
- Start
- Mar 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 7
01
Overview
Phase 4, open-label trial of teriparatide in osteoporosis (2 arms), sponsored by Sanofi. Primary endpoint: Change from baseline in N-terminal propeptide of type I collagen (P1NP) at 3 months. Started Mar 2004; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00130403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130403.